|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Mestier L, Lardière-Deguelte S, Volet
J, Kianmanesh R and Bouché O: Recent insights in the therapeutic
management of patients with gastric cancer. Dig Liver Dis.
48:984–994. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park JS, Kim HS, Bae YS, Cheong JH, Rha
SY, Noh SH and Kim H: Prognostic significance and frequency of EGFR
expression and amplification in surgically resected advanced
gastric cancer. Jpn J Clin Oncol. 46:507–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng X, Qin JJ, Zheng BS, Huang LL, Xie XY
and Zhou HF: Association of epidermal growth factor receptor (EGFR)
gene polymorphism with lung cancer risk: A systematic review. J
Recept Signal Transduct Res. 34:333–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee HJ, Seo AN, Kim EJ, Jang MH, Kim YJ,
Kim JH, Kim SW, Ryu HS, Park IA, Im SA, et al: Prognostic and
predictive values of EGFR overexpression and EGFR copy number
alteration in HER2-positive breast cancer. Br J Cancer.
112:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berger MS, Greenfield C, Gullick WJ, Haley
J, Downward J, Neal DE, Harris AL and Waterfield MD: Evaluation of
epidermal growth factor receptors in bladder tumours. Br J Cancer.
56:533–537. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Onguru O, Scheithauer BW, Kovacs K, Vidal
S, Jin L, Zhang S, Ruebel KH and Lloyd RV: Analysis of epidermal
growth factor receptor and activated epidermal growth factor
receptor expression in pituitary adenomas and carcinomas. Mod
Pathol. 17:772–780. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Tang H, Lin J, Hu Y, Luo G, Luo
Z, Cheng C and Wang P: Clinicopathologic and prognostic
significance of human epidermal growth factor receptor in patients
with gastric cancer: An updated meta-analysis. Oncotarget.
8:17202–17215. 2017.PubMed/NCBI
|
|
11
|
Hong L, Han Y and Brain L: The role of
epidermal growth factor receptor in prognosis and treatment of
gastric cancer. Expert Rev Gastroenterol Hepatol. 8:111–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Zhang H, Ning T, Wang X, Liu R, Yang
H, Han Y, Deng T, Zhou L, Zhang L, et al: MiR-520b/e regulates
proliferation and migration by simultaneously targeting EGFR in
gastric cancer. Cell Physiol Biochem. 40:1303–1315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiel A and Ristimäki A: Targeted therapy
in gastric cancer. APMIS. 123:365–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Yang J, Cai J, Song X, Deng J,
Huang X, Chen D, Yang M, Wery JP, Li S, et al: A subset of gastric
cancers with EGFR amplification and overexpression respond to
cetuximab therapy. Sci Rep. 3:29922013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kozomara A and Griffiths-Jones S: MiRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu Y, Zhang H, Duan J, Liu R, Deng T, Bai
M, Huang D, Li H, Ning T, Zhang L, et al: MiR-17-5p regulates cell
proliferation and migration by targeting transforming growth
factor-β receptor 2 in gastric cancer. Oncotarget. 7:33286–33296.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Duan J, Qu Y, Deng T, Liu R,
Zhang L, Bai M, Li J, Ning T, Ge S, et al: Onco-miR-24 regulates
cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Protein Cell. 7:141–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Li Q, Wang J, Guo X, Jiang X, Ren
Z, Weng C, Sun G, Wang X, Liu Y, et al: Identification and
characterization of novel amphioxus microRNAs by Solexa sequencing.
Genome Biol. 10:R782009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Canu V, Sacconi A, Lorenzon L, Biagioni F,
Lo Sardo F, Diodoro MG, Muti P, Garofalo A, Strano S, D'Errico A,
et al: MiR-204 down-regulation elicited perturbation of a gene
target signature common to human cholangiocarcinoma and gastric
cancer. Oncotarget. 8:29540–29557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greenlee RT, Murray T, Bolden S and Wingo
PA: Cancer statistics, 2000. CA Cancer J Clin. 50:7–33. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bennett C, Paterson IM, Corbishley CM and
Luqmani YA: Expression of growth factor and epidermal growth factor
receptor encoded transcripts in human gastric tissues. Cancer Res.
49:2104–2111. 1989.PubMed/NCBI
|
|
29
|
Lemmon MA, Schlessinger J and Ferguson KM:
The EGFR family: Not so prototypical receptor tyrosine kinases.
Cold Spring Harb Perspect Biol. 6:a0207682014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song S and Ajani JA: The role of microRNAs
in cancers of the upper gastrointestinal tract. Nat Rev
Gastroenterol Hepatol. 10:109–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nassar FJ, Nasr R and Talhouk R: MicroRNAs
as biomarkers for early breast cancer diagnosis, prognosis and
therapy prediction. Pharmacol Therap. 172:34–49. 2016. View Article : Google Scholar
|
|
32
|
Naidu S, Magee P and Garofalo M:
MiRNA-based therapeutic intervention of cancer. J Hematol Oncol.
8:682015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Cao KE, Wang S, Chen J, He B, He
G, Chen Y, Peng B and Zhou J: MicroRNA-138 suppresses
proliferation, invasion and glycolysis in malignant melanoma cells
by targeting HIF-1α. Exp Ther Med. 11:2513–2518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang B, Mu W, Wang J, Lu J, Jiang S, Li
L, Xu H and Tian H: MicroRNA-138 functions as a tumor suppressor in
osteosarcoma by targeting differentiated embryonic chondrocyte gene
2. J Exp Clin Cancer Res. 35:692016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun DK, Wang JM, Zhang P and Wang YQ:
MicroRNA-138 regulates metastatic potential of bladder cancer
through ZEB2. Cell Physiol Biochem. 37:2366–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan X, Wang S, Liu M, Lu Z, Zhan Y, Wang
W and Xu AM: Histological and pathological assessment of miR-204
and SOX4 levels in gastric cancer patients. Biomed Res Int.
2017:68946752017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen X, Liu XS, Liu HY, Lu YY and Li Y:
Reduced expression of serum miR-204 predicts poor prognosis of
gastric cancer. Genet Mol Res. 15:doi: 10.4238/gmr.15027702.
2016.
|
